Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma

This study is currently recruiting participants.

Study NCT00077285 Information provided by National Cancer Institute (NCI)

First Received: February 10, 2004 Last Updated: July 7, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	October 2010 (Final data collection date for primary outcome measure)